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RED CELL HOMEOSTASIS
Red blood cell production and the supply of oxygen to the 
tissues is tightly controlled by a negative feedback mechanism 
involving the kidney.  Any fall in the level of oxygen is sensed 
by the kidney, which then synthesizes the erythroid growth 
factor, erythropoietin (Epo).  This growth factor acts upon 
bone marrow erythroid precursors to increase the number 
of  circulating  red  blood  cells  thus  correcting  the  oxygen 
deficit.  The EPO gene, which encodes erythropoietin, is 
transcriptionally regulated by the Hypoxia Inducible Factor 
(HIF) transcription complex. The HIF complex is composed 
of  two  different  subunits,  alpha  and  beta  (also  known  as 
ARNT),  both  constitutively  expressed. The  alpha  subunit 
is  continually  synthesized  but  in  the  presence  of  oxygen 
it  is  undetectable  due  to  degradation  by  the  proteasome. 
A family of enzymes, prolyl hydroxylase domain proteins 
(PHD) of which there are 3 members (PHD1, PHD2 and 
PHD3), are able to hydroxylate key prolines in the oxygen 
dependent degradation (ODD) domain of HIFalpha and these 
enzymes are only active in the presence of oxygen (Fig 1). 
The von Hippel Lindau (VHL) protein is able to associate 
with HIFalpha once it is hydroxylated and then molecules of 
ubiquitin are added. This is the signal that sends HIFalpha to 
the proteasome for degradation. As the level of oxygen falls 
the PHD enzymes are no longer active resulting in less and 
less HIFalpha being degraded (Fig 1). Consequently, all the 
genes under the control of the HIF transcription complex, 
which includes EPO, are elevated. Once the oxygen deficit is 
corrected by the enhanced production of red blood cells the 
oxygen tension rises and HIFalpha is increasingly degraded.
EYTHROCYTOSIS
Erythrocytosis is a rare red cell disorder that can arise from 
diverse molecular origins. It is characterised by an elevated 
haematocrit and haemoglobin level. There is no accompanying 
increase  in  the  number  of  white  cells  or  platelets.  Both 
sporadic and familial forms exist and age of presentation is 
highly variable. Individuals with erythrocytosis exhibit a wide 
range of serum Epo levels and this reflects the heterogeneity 
of this disorder.
Over the last decade a registry of erythrocytosis individuals 
has been established at the Belfast City Hospital to which 
patients from the UK and Ireland been referred1. Interestingly, 
there is a preponderance of males with a ratio of 1.7 males 
to every female2. The mean age of erythrocytosis individuals 
present on the data base is 37 years2. Most individuals have 
inappropriately normal (46%) or raised (26%) serum Epo 
levels2 indicating that a significant cause of erythrocytosis 
is dysregulation of Epo synthesis via the oxygen sensing 
pathway.
Investigation of the VHL and PHD2 proteins in erythrocytosis 
individuals has detected several different mutations. One VHL 
mutation, Arg200Trp predominates, and was first detected in 
a population in the Chuvash region of Russia3. Further studies 
revealed its worldwide distribution and the possibility of a 
common origin for most cases of this mutation4. In contrast, 
only a few different PHD2 mutations have been 5-7. However, 
there remains a large cohort of erythrocytosis individuals 
who also possibly have an underlying defect in the oxygen 
sensing  pathway.  Previous  investigation  of  HIF-1alpha 
had not revealed any causative mutations8 but we set about 
investigating  HIF-2alpha  as  murine  studies  indicated  this 
isoform was the major controller of Epo synthesis9.
THE GLY537TRP HIF-2ALPHA MUTATION
Screening  the  ODD  region  of  HIF-2alpha  detected  a 
heterozygous base change of G to T at base 1609 in exon 12 
(Fig 2) in a young man as reported in the New England Journal 
Fig 1.  The control of erythropoietin synthesis by the oxygen 
sensing pathway. 
In the presence of oxygen HIFalpha is hydroxylated by the prolyl 
hydroxylase PHD2 and once modified the von Hippel Lindau (VHL) 
protein is able to bind. HIFalpha is then targeted to the proteasome. In 
the absence of oxygen HIFalpha is not hydroxylated and VHL does not 
associate thereby allowing HIFalpha to bind to hypoxia response elements 
(HRE) in target genes such as EPO.© The Ulster Medical Society, 2008.
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of Medicine10. This mutation resulted in the replacement of 
the  amino  acid  glycine  at  position  537  with  tryptophan. 
Screening a group of health control samples did not detect 
this  same  mutation  suggesting  it  may  be  associated  with 
erythrocytosis. The propositus presented with erythrocytosis 
at the age of 23 years exhibiting an elevated haemoglobin 
level  of  21.7  g/dL  and  a  haematocrit  of  0.64.  Further 
investigation of his family revealed that both his mother and 
maternal grandmother also had erythrocytosis presenting at 
the ages of 35 and 54 years respectively (Fig 3). Mutation 
analyses confirmed both these individuals also possessed the 
Gly537Trp mutation. Measurement of serum Epo levels in 
the three erythrocytosis individuals revealed they were well 
above the normal range for the assay. The platelet and white 
cell counts for all three erythrocytosis family members were 
normal. Other non-affected family members did not possess 
the Gly537Trp mutation.
GLY537TRP HIF-2ALPHA FUNCTIONAL STUDIES
To confirm whether the Gly537Trp mutation could indeed 
result in erythrocytosis recombinant protein was prepared 
from  a  bacterial  plasmid  containing  a  DNA  copy  of  the 
mutant gene. Using this recombinant protein assays were 
performed to discover if the mutation affected the function 
of HIF-2alpha. Less association of PHD2 with HIF-2alpha 
was  detected  which  would  affect  the  ability  of  PHD2  to 
hydroxylate HIF-2alpha. The hydroxylation of HIF-2alpha 
is important for the association of VHL so we wanted to 
establish if the mutant protein was hydroxylated to the same 
level as the wild type protein. We found that the mutant was 
less hydroxylated and subsequently detected less association 
with its binding partner VHL. We were also able to show that 
the Gly537Trp HIF-2alpha protein was more stable than wild 
type and was able to up-regulate HIF-2alpha target genes. 
Thus it could be inferred that Epo synthesis would also be 
elevated.
The amino acid sequence of HIF-2alpha is highly conserved 
and Gly537 is present in this isoform from other species such 
as mouse, chicken and frog but is absent in the other two 
isoforms of HIFalpha. The replacement of the structurally 
small glycine with the bulkier tryptophan amino acid would 
cause  disruption  of  the  ODD  region. This  would  prevent 
optimal binding of PHD2, thus reducing hydroxylation and 
the association of VHL, resulting in decreased ubiquitinylation 
of HIF-2alpha (Fig 4). Consequently, HIF target genes would 
be transcribed at a higher rate.
SUMMARY
A  mutation  of  HIF-2alpha  has  been  detected  in  three 
generations of a family with erythrocytosis and the mutation 
co-segregated with the erythrocytosis phenotype. Functional 
studies revealed that Gly537Trp mutation would significantly 
impair the function of HIF-2alpha thus leading to increased 
synthesis of Epo. In addition to VHL and PHD2 a further 
member of the oxygen sensing pathway, namely HIF-2alpha, 
can be a cause of erythrocytosis. Furthermore, HIF-2alpha 
plays an important role in the regulation of Epo production. 
Continued study of idiopathic cases of erythrocytosis with 
raised serum Epo will reveal whether HIF-2alpha will be a 
major cause of erythrocytosis on par with VHL.
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Fig 3.  Pedigree of family with hereditary erythrocytosis. 
Three generations of one family were found to have erythrocytosis and the 
first noted case is indicated by an arrow. Squares and circles represent male 
and female family members respectively, while solid symbols indicate 
erythrocytosis individuals. Included in a table are salient haematological 
features at the time of presentation and a recent serum erythropoietin level.
Fig 4.  The impact of the Gly537Trp mutation on the function of 
HIF-2alpha. 
The replacement of glycine with a large amino acid would prevent both 
the association of PHD2 and VHL to HIF-2alpha. Consequently neither 
hydroxylation or ubiquitinylation of HIF-2alpha would occur. HIF-2alpha 
is able to evade proteasomal degradation and bind to HRE of EPO to 
increase transcription.
Fig 2.  Detection of the c.1609G>T mutation in exon 12 of HIF2A. 
Exon 12 was amplified by polymerase chain reaction (PCR) from DNA 
extracted from peripheral blood. The PCR product was sequenced and 
replacement of G with T at 1609 was discovered as indicated by arrow. 
Bases are as follows: G = black; A = green; T = red; C = blue.© The Ulster Medical Society, 2008.
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